Recent Updates
Recently added Catalysts

Carvedilol

Phase 1

Healthy | Small molecule | Other |Dr. Reddy's Laboratories Ltd|Last Updated: Feb 8, 2010

Success Probability

Subscribe to view

Market & Valuation

Subscribe to view

Trial Design

RandomizedACTIVE_CONTROLLED
Total Trials2
Total Enrollment60

FDA Designations

No designations recorded

Clinical trial landscape

Carvedilol · 2 trials · 1 indication

Phase 1 2
NCT01064154Carvedilol 25 mg Film-coated Tablets, Bioequivalence Study of Dr. Reddys Under Fasting ConditionsHealthy
COMPLETED36 Analytics
NCT01064180Carvedilol 25 mg Film-coated Tablets, Bioequivalence Study of Dr. Reddys Under Fed ConditionsHealthy
COMPLETED24 Analytics
PHASE1COMPLETED
Carvedilol 25 mg Film-coated Tablets, Bioequivalence Study of Dr. Reddys Under Fasting Conditions
Healthy
NCT0106415436
Unlock trial analytics
PHASE1COMPLETED
Carvedilol 25 mg Film-coated Tablets, Bioequivalence Study of Dr. Reddys Under Fed Conditions
Healthy
NCT0106418024
Unlock trial analytics

Study Endpoints

Primary Endpoints

Carvedilol Tablets, 25 mg Bioequivalence Study Of Dr Reddys under fasting condition
4 months
Carvedilol Tablets, 25 mg Bioequivalence Study Of Dr Reddys under non-fasting condition
4 months
Unlock Study Endpoints

Study Design & Arms

AllocationRANDOMIZED
MaskingNONE
ModelCROSSOVER
PurposeTREATMENT

Treatment Arms

ArmTypeDescription
CarvedilolEXPERIMENTALCarvedilol Tablets 25 mg of Dr Reddys Laboratories Limited
CoregACTIVE_COMPARATORCoreg Tablets 25 mg of GlaxoSmithKline

Interventions

NameTypeDescription
CarvedilolDRUGCarvedilol Tablets 25 mg
Unlock Study Design Details

Eligibility Criteria

Age Range18 Years to N/A
SexALL
Healthy VolunteersYes

Inclusion Criteria: Subjects enrolled in this study will be members of the community at large. The recruitment advertisements may be done using different media (e.g. radio, newspaper, Anapharm Inc. Website, Anapharm Inc. volunteers' data base). Subjects must meet all of the following criteria in or...

Unlock Eligibility Criteria